1.	Phase III Randomized Study of IM-862 in Patients With Mucocutaneous AIDS-Related Kaposi's Sarcoma Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: AMC-013, AMC-KS-20898-01, NCT00003879
2.	Phase II Randomized Study of Fluorouracil With or Without IM-862 and Irinotecan With or Without IM-862 in Patients With Previously Untreated or Recurrent Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 02/2002) Phase: Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: LAC-USC-3C993, NCI-G00-1812, NCT00006037
3.	Phase II Randomized Study of Adjuvant Paclitaxel, Carboplatin, and IM-862 in Patients With Optimally Resected Stage III Ovarian Epithelial or Primary Peritoneal Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CYTRAN-IM862-302, FHCRC-5156, NCT00017303
4.	Phase I Study of IM-862 in Patients with Recurrent Ovarian Cancer (Summary Last Modified 01/2001) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-5O984, NCI-G99-1503, NCT00003773